» Articles » PMID: 15705927

Adipocyte Fatty Acid-binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-like Receptor Agonists

Overview
Date 2005 Feb 12
PMID 15705927
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Toll-like receptors (TLRs) recognize pathogens and mediate signaling pathways important for host defense. Recent studies implicate TLR polymorphisms in atherosclerosis risk in humans. Adipocyte fatty acid-binding protein (aP2) is present in macrophages and has an important role in atherosclerotic plaque development. We investigated aP2 expression in RAW 264.7 cells treated with lipopolysaccharide (LPS) and other TLR agonists and assessed lipid accumulation in these activated murine macrophages.

Methods And Results: Stimulation with LPS, a TLR4 ligand, resulted in a 56-fold increase in aP2 mRNA expression, and zymosan, a TLR2 ligand, induced an approximately 1500-fold increase. Polyinosine: polycytidylic acid (poly I:C), a TLR3 ligand, led to a 9-fold increase. Levels of aP2 protein were significantly increased in LPS or zymosan-treated macrophages compared with control or poly I:C-treated cells. In addition, the cholesteryl ester content of LPS or zymosan-treated macrophages was approximately 5-fold greater in the presence of low-density lipoprotein, and triglyceride content was approximately 2-fold greater in the absence of exogenous lipid than control or poly I:C-treated cells.

Conclusions: Expression of macrophage aP2 is induced on TLR activation and parallels increases in cholesteryl ester and triglyceride levels. These results provide a molecular link between the known roles of TLR and aP2 in foam cell formation.

Citing Articles

Fatty Acid Binding Protein 4 Could Be a Linking Biomarker Between Periodontitis and Systemic Diseases.

Song J, Ok S, Kwon E, Kim H, Lee J, Joo J Biomedicines. 2025; 13(2).

PMID: 40002815 PMC: 11853709. DOI: 10.3390/biomedicines13020402.


Activation of pregnane X receptor sensitizes alcoholic steatohepatitis by transactivating fatty acid binding protein 4.

Zhang Y, Hu B, Guan S, Li P, Guo Y, Xu P Acta Pharm Sin B. 2024; 14(11):4776-4788.

PMID: 39664417 PMC: 11628830. DOI: 10.1016/j.apsb.2024.08.029.


Multiple sclerosis and obesity: The role of adipokines.

Correale J, Marrodan M Front Immunol. 2022; 13:1038393.

PMID: 36457996 PMC: 9705772. DOI: 10.3389/fimmu.2022.1038393.


Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation.

Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X Front Endocrinol (Lausanne). 2022; 13:873699.

PMID: 35909571 PMC: 9329830. DOI: 10.3389/fendo.2022.873699.


Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against renal ischemia-reperfusion injury.

Shi M, Huang R, Guo F, Li L, Feng Y, Wei Z RSC Adv. 2022; 8(27):15207-15214.

PMID: 35541316 PMC: 9079974. DOI: 10.1039/c8ra00122g.